Showing results (441-450 of 456) with videos related to
Sort By:
Pageof 46
Hepatology International|November 21, 2024
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024George Lau, Shuntaro Obi, Jian Zhou, et al.Journal of Viral Hepatitis|September 13, 2025
Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide AnalogsAngela Chau, Jie Li, Dae Won Jun, et al.Hepatology International|January 21, 2024
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from TaiwanMing-Lung Yu, Chi-Ming Tai, Lein-Ray Mo, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 3, 2021
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in TaiwanChi-Yi Chen, Chung-Feng Huang, Pin-Nan Cheng, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 6, 2022
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in TaiwanChing-Chu Lo, Chung-Feng Huang, Pin-Nan Cheng, et al.Clinical and Molecular Hepatology|January 9, 2024
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry programMing-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, et al.Infectious Diseases and Therapy|December 30, 2021
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in TaiwanPin-Nan Cheng, Lein-Ray Mo, Chun-Ting Chen, et al.Journal of Hepatology|June 21, 2024
Sex and ethnic disparities in hepatitis B evaluation and treatment across the worldSahith Kudaravalli, Daniel Q Huang, Ming-Lun Yeh, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2021
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)Chung-Feng Huang, Kuo-Chih Tseng, Pin-Nan Cheng, et al.Viruses|February 26, 2022
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting AntiviralsYen-Chun Chen, Te-Sheng Chang, Chien-Hung Chen, et al.Pageof 46